Prognostic Value of Inflammatory Biomarkers in Patients with Advanced Stage Non-Small Cell Lung Cancer - Amsterdam 2025

Predictive and prognostic evaluation of clinical markers and biomarkers in lung cancer

Chair(s): Daniela Xhemalaj, Eric Daniel Tenda

Session type: Poster session

Prognostic Value of Inflammatory Biomarkers in Patients with Advanced Stage Non-Small Cell Lung Cancer

Chaima Habouria

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

MCT1-mediated histone lactylation modulates lung cancer cell sensitivity to T-cell-mediated killing by influencing mitochondrial dysfunction

Qiong Zhou

Poster

Abstract

TGFBI modulates lung cancer cell invasion, but is independent of metastasis & survival

Martin Kuchta

Poster

Abstract

Prognostic Value of Inflammatory Biomarkers in Patients with Advanced Stage Non-Small Cell Lung Cancer

Chaima Habouria

Poster

Abstract

Correlation of PD-L1 expression between biopsies and surgical specimens in Non-Small Cell Lung Cancer (NSCLC)

Filipe Santos Raposo

Poster

Abstract

Predictive factors of morbidity and mortality after pneumonectomy

Mahdi Abdennadher

Poster

Abstract

Multi-gene molecular testing in non-small cell lung cancer (NSCLC): the importance of quality assurance strategies

Urszula Lechowicz

Poster

Abstract

Impact of pulmonary embolism on lung cancer prognosis: A case-control study

Ruiyuan Yang

Poster

Abstract

A single centre retrospective review of factors associated with mortality in lung cancer.

Sarah Ahmed

Poster

Abstract

Survival Predictors in Lung Cancer Patients Five Years After Initial Diagnosis

Noelia Borja Vargas

Poster

Abstract

The prognostic value of baseline serum D-dimer concentration in lung cancer - a post hoc analysis of a prospective cohort study

Joana Sofia Pereira De Magalhães Ferreira

Poster

Abstract

Association between serum ?-glutamyl transferase level and lung cancer risk in females

Chiwook Chung

Poster

Abstract

Prognostic implication of malignant pleural metastases in stage M1a non-small cell lung cancer (NSCLC) in a Dutch real-world cohort

Anneloes L. Noordhof

Poster

Abstract

Relationship Between Telomere Length and Pulmonary Toxicity in Patients with Locally Advanced Unresectable Non-small cell lung cancer (NSCLC)

Alfredo Marín Muñiz

Poster

Abstract

Telomere Length and Survival in Patients with Locally Advanced UnresectableNon-small Cell Lung Cancer (NSCLC): Is There a Relationship?

Alfredo Marín Muñiz

Poster

Abstract

Laboratory findings as prognostic factors of progression-free survival and overall survival in patients with stage IV lung adenocarcinoma

Andrej Zecevic

Poster

Abstract

Refining lung cancer prognostication: impact of the 9th edition of the tumor, node and metastasis classification (TNM-9) staging updates

Joana Sofia Pereira De Magalhães Ferreira

Poster

Abstract

Improved efficacy of immune checkpoint inhibitor with TGR5 inhibition in non-small cell lung cancer

Lifang Zhao

Poster

Abstract

Construction of a LncRNA Signature-Based Predictive Nomogram for Lung Adenocarcinoma

Zhimin Zeng

Poster

Abstract

Transitioning to NGS in NSCLC Molecular Diagnosis: Insights from a Portuguese Oncology Centre

Joana Da Silva Cruz Gameiro Duarte

Poster

Abstract

The Systemic Inflammation Response Index (SIRI) and C-Reactive protein (CRP) as Prognostic indicators in patients with advanced non-small cell lung cancer (NSCLC) undergoing chemotherapy

Chaima Habouria

Poster

Abstract

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}